Login / Signup

Risk of herpes zoster following mRNA COVID-19 vaccine administration.

Ana FloreaJun WuLei QianBruno J LewinLina S SyI-Chun LinJennifer H KuHung Fu Tseng
Published in: Expert review of vaccines (2023)
Our findings suggest a potential increased risk of HZ after a second dose of mRNA vaccines, potentially driven by the increased risk in individuals aged ≥50 years without history of zoster vaccination.
Keyphrases
  • coronavirus disease
  • sars cov
  • binding protein
  • human health